Pastan, Ira

Pastan, Ira

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	10/6/2005	United States Patent and Trademark Office	10552515	Gene Expressed In Prostate Cancer, Methods And Use Thereof	Applicant
	6/1/2005	United States Patent and Trademark Office	10537061	Recombinant immunotoxin and use in treating tumors	Applicant
	3/4/2003	United States Patent and Trademark Office	10363233	Xage-1, a gene expressed in multiple cancers, and uses there...	Applicant
	12/4/2002	United States Patent and Trademark Office	10297337	Pegylation of linkers improves antitumor activity and reduce...	Applicant
	8/9/2002	United States Patent and Trademark Office	10203675	Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Im...	Applicant
	1/11/2002	United States Patent and Trademark Office	10031158	T-cell Receptor Gamma Alternate Reading Frame Protein, (tarp...	Applicant
	11/20/2001	United States Patent and Trademark Office	09979539	Anti-mesothelin Antibodies Having High Binding Affinity	Applicant
	9/17/1999	United States Patent and Trademark Office	09397951	Nucleic Acids Encoding Immunotoxins Containing A Disulfide-s...	Applicant
	1/8/1999	United States Patent and Trademark Office	09227693	Methods of inhibiting the growth of cells bearing Lewis y an...	Applicant
	12/17/1998	United States Patent and Trademark Office	09215035	Mesothelin, A Differentiation Antigen Present On Mesothelium...	Applicant
	1/12/1998	United States Patent and Trademark Office	08776271	Mesothelium Antigen And Methods And Kits For Tageting It	Applicant
	12/5/1997	United States Patent and Trademark Office	08973626	Cellular Apoptosis Susceptibility Protein (csp) And Antisens...	Applicant
	8/21/1997	United States Patent and Trademark Office	08918190	Cellular Apoptosis Susceptibility Protein (csp)	Applicant
	1/8/1997	United States Patent and Trademark Office	08722258	Circularly Permuted Ligands And Circularly Permuted Chimeric...	Applicant
	12/3/1996	United States Patent and Trademark Office	08759804	Tumor-specific Antibody Fragments, Fusion Proteins, And Uses...	Applicant
	6/7/1995	United States Patent and Trademark Office	08480662	Cellular Apoptosis Susceptibility Protein (csp) And Antisens...	Applicant
	6/6/1995	United States Patent and Trademark Office	08467264	Pseudomonas Exotoxins Of Low Animal Toxicity And High Cytoci...	Applicant
	6/6/1995	United States Patent and Trademark Office	08467959	Methods For Reducing Tumor Cell Growth By Using Antibodies W...	Applicant
	6/5/1995	United States Patent and Trademark Office	08461233	Target-specific, Cytotoxic, Recombinant Pseudomonas Exotoxin	Applicant
	12/22/1994	United States Patent and Trademark Office	08363203	Method For Diagnosing Tumors Using Mouse Monoclonal Antibodi...	Applicant
	10/28/1994	United States Patent and Trademark Office	08331396	Humanized B-3 Antibody Fragments,fusion Proteins, And Uses T...	Applicant
	10/28/1994	United States Patent and Trademark Office	08331397	Himeric And Mutationally Stabilized Tumor-specific B1, B3 An...	Applicant
	10/28/1994	United States Patent and Trademark Office	08331398	Single Chain B3 Antibody Fusinon Proteins And Their Uses	Applicant
	10/1/1993	United States Patent and Trademark Office	08130322	Pseudomonas Exotoxins (pe) And Conjugates Therof Having Lowe...	Applicant
	4/22/1993	United States Patent and Trademark Office	08051133	Mouse Monoclonal Antibodies	Applicant
	9/30/1991	United States Patent and Trademark Office	07767331	Recombinant Immunotoxins	Applicant
	5/14/1991	United States Patent and Trademark Office	07701576	Clone For Human Multidrug Resistance Gene	Applicant
	12/3/1990	United States Patent and Trademark Office	07620939	Recombinant Immunotoxin Composed Of A Single Chain Antibody ...	Applicant
	10/12/1990	United States Patent and Trademark Office	07596289	Mouse Monoclonal Antibodies Specific For Normal Primate Tiss...	Applicant
	5/11/1990	United States Patent and Trademark Office	07522182	Pseudomonas Exotoxins Of Low Animal Toxicity And High Cytoci...	Applicant
	5/12/1989	United States Patent and Trademark Office	07351448	Selectively Cytotoxic Il-4-pe40 Fusion Protein	Applicant
	6/3/1988	United States Patent and Trademark Office	07202782	Retrovirus Vector Carrying Mdr1 Cdna Which Transmits Multidr...	Applicant
	6/3/1988	United States Patent and Trademark Office	07202783	Gene Therapy Using Gene Fusions For Genetic Or Acquired Diso...	Applicant

33 Rows Total

Outside Counsel (530)

	Last Name	First Name	Middle Name	Firm	Location
	Weber	Ellen		JACQUELINE S. LARSON
	Weber	Kenneth	W.	Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Weight	Clark	F.	Kilpatrick Townsend & Stockton, LLP
	Weiss	David	Nathaniel	Knobbe Martens Olson & Bear LLP	Los Angeles, CA
	Wengreen	Eric		Knobbe Martens Olson & Bear LLP
	Wenk	Nathan		Knobbe Martens Olson & Bear LLP	Irvine, CA
	Wetherald	Cort		Kilpatrick Townsend & Stockton, LLP	San Diego, CA
	Williams	Camilla	Camp	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Williams	Tiffany	L.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Willink	Christopher	L.	Kilpatrick Townsend & Stockton, LLP
	Wilson	Mary			CRESCENT CITY, CA
	Winn	Robert		Knobbe Martens Olson & Bear LLP
	WISEMAN	THOMAS			ATLANTA, GA
	Wolff	Kristen	L.	Foley & Lardner, LLP	Palo Alto, CA
	Wong	Zi		Knobbe Martens Olson & Bear LLP
	Woods	Michael	Eugene	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Woods	Michael		Acco Brands, Inc.
	Wooten	Alyson	Lynn	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Wray	Caroline	K.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Wylie	Roger	D.	MICHALIK & WYLIE, PLLC	BELLEVUE, IL
	Xia	Qing		Knobbe Martens Olson & Bear LLP
	Yamato	Lori	Lee	Knobbe Martens Olson & Bear LLP	Irvine, CA
	Yee	Thomas	Y.	Knobbe Martens Olson & Bear LLP	Irvine, CA
	YIN	LU		Kilpatrick Townsend & Stockton, LLP
	Young	Daniel	Shaw	Kilpatrick Townsend & Stockton, LLP	Denver, CO
	Zelkind	Boris		Knobbe Martens Olson & Bear LLP	San Diego, CA
	Zigmant.	John		Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Zoretic	Marko	Romeo	Knobbe Martens Olson & Bear LLP	Irvine, CA
	Zovko	Nicholas	Matthew	Knobbe Martens Olson & Bear LLP	Riverside, CA
	Zylstra	Eric		Kilpatrick Townsend & Stockton, LLP

530 Rows Total	Page 6 of 6 | Go To

Pastan, Ira has not filed any forms with the United States Securities and Exchange Commission.

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	4/4/2012	The United States Of America	Assignee	Application Publication	13207856 20120177567	Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-... Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-...
	1/13/2012	The Government Of The United States Of A...	Assignee	Application Publication Patent	13259138 20120107933 8460660	Anti-mesothelin Antibodies Anti-mesothelin Antibodies Anti-mesothelin Antibodies
	11/18/2011	The United States Of America	Assignee	Application Publication Patent	13265490 20120052116 8748390	Immunogenic Epitopes Of Ngep Antigen Immunogenic Epitopes Of Ngep Antigen Immunogenic Epitopes Of Ngep Antigen
	6/20/2011	The Government Of The United States Of A...	Assignee	Application Publication Patent	13133136 20110236385 8623828	Blocking Mesothelin Peptide Fragments Blocking Mesothelin Peptide Fragments Graph Based Flexible Service Discovery And Management System And Method
	5/3/2010	The United States Of America	Assignee	Application Publication Patent	13265490 20120052116 8748390	Immunogenic Epitopes Of Ngep Antigen Immunogenic Epitopes Of Ngep Antigen Immunogenic Epitopes Of Ngep Antigen
	10/27/2009	United States Government, Nih	Assignee	Application Publication	12418956 20100047164	Single Chain Antibodies that Bind to Chondroitin Sulfate Proteoglycans Single Chain Antibodies that Bind to Chondroitin Sulfate Proteoglycans
	5/25/2004	Shirankai Kyoto University Faculty Of Me...	Assignee	Application Publication	10493488 20060058336	Pharmaceutical composition for treatment of drug dependence Pharmaceutical composition for treatment of drug dependence
	3/4/2003	Department Of Health And Human Services	Assignee	Application Publication	10363233 20040087772	Xage-1, a gene expressed in multiple cancers, and uses thereof Xage-1, a gene expressed in multiple cancers, and uses thereof
	1/29/2003	Duke University	Assignee	Application Publication Patent	10203675 20030211097 7129332	Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B...
	1/29/2003	Health And Human Services, The Governmen...	Assignee	Application Publication Patent	10203675 20030211097 7129332	Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B...
	12/4/2002	Department Of Health And Human Services,...	Assignee	Application Publication	10297337 20040018203	Pegylation of linkers improves antitumor activity and reduces toxicity o... Pegylation of linkers improves antitumor activity and reduces toxicity o...
	8/9/2002	Duke University	Assignee	Application Publication Patent	10203675 20030211097 7129332	Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B...
	8/9/2002	Government Of The United States Of Ameri...	Assignee	Application Publication Patent	10203675 20030211097 7129332	Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B... Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins B...
	4/29/2002	Health And Human Services, Government Of...	Assignee	Application Patent	08913370 6518061	Il-13 Receptor Specific Chimeric Proteins And Uses Therof Il-13 Receptor Specific Chimeric Proteins And Uses Therof
	11/20/2001	Government Of The United States Of Ameri...	Assignee	Application Patent	09979539 7081518	Anti-mesothelin Antibodies Having High Binding Affinity Anti-mesothelin Antibodies Having High Binding Affinity
	8/2/2001	Health And Human Services, Government Of...	Assignee	Application Patent	09763393 7399827	Page-4, An X-linked Gage-like Gene Expressed In Normal And Neoplastic Pr... Page-4, An X-linked Gage-like Gene Expressed In Normal And Neoplastic Pr...
	2/23/2000	United States Of American As Represented...	Assignee	Application Patent	09381497 7541034	Recombinant Antibodies And Immunoconjugates Targeted To Cd-22 Bearing Ce... Recombinant Antibodies And Immunoconjugates Targeted To Cd-22 Bearing Ce...
	7/30/1999	Health And Human Services, Government Of...	Assignee	Application Patent	09297851 6426075	Protease-activatable Pseudomonas Exotoxin A-like Proproteins Protease-activatable Pseudomonas Exotoxin A-like Proproteins
	4/13/1998	Health And Human Services, United States...	Assignee	Application Patent	08973626 6156564	Cellular Apoptosis Susceptibility Protein (csp) And Antisense Csp Cellular Apoptosis Susceptibility Protein (csp) And Antisense Csp
	1/12/1998	Health And Human Services, Government Of...	Assignee	Application Patent	08776271 6083502	Mesothelium Antigen And Methods And Kits For Tageting It Mesothelium Antigen And Methods And Kits For Tageting It
	8/27/1997	Health And Human Services, Government Of...	Assignee	Application Patent	08809668 5980895	Immunotoxin Containing A Disulfide-stablized Antibody Fragment Joined To... Immunotoxin Containing A Disulfide-stablized Antibody Fragment Joined To...
	7/7/1997	Health And Human Services, Department Of...	Assignee	Application Patent	08722258 6011002	Circularly Permuted Ligands And Circularly Permuted Chimeric Molecules Circularly Permuted Ligands And Circularly Permuted Chimeric Molecules
	10/16/1995	Health And Human Services	Assignee	Application Patent	08480662 5759782	Cellular Apoptosis Susceptibility Protein (csp) And Antisense Csp Cellular Apoptosis Susceptibility Protein (csp) And Antisense Csp
	9/11/1995	Health And Human Services, United States...	Assignee	Application Patent	08481730 5849998	Transgenic Animals Expressing A Multidrug Resistance Cdna Transgenic Animals Expressing A Multidrug Resistance Cdna
	9/11/1995	Health And Human Services, Department Of...	Assignee	Application Patent	08467959 5846535	Methods For Reducing Tumor Cell Growth By Using Antibodies With Broad Tu... Methods For Reducing Tumor Cell Growth By Using Antibodies With Broad Tu...
	6/12/1995	Health And Human Services, United States	Assignee	Application Patent	08416623 5928637	Methods Of Inducing Multidrug Resistance Using Human Mdr1 Cdna Methods Of Inducing Multidrug Resistance Using Human Mdr1 Cdna
	5/18/1995	Health And Human Services, Department Of...	Assignee	Application Patent	08404685 5614191	Il-13 Receptor Specific Chimeric Proteins And Uses Thereof Il-13 Receptor Specific Chimeric Proteins And Uses Thereof
	3/31/1995	United States Of America	Assignee	Application Patent	08331396 5889157	Humanized B-3 Antibody Fragments,fusion Proteins, And Uses Thereof. Uses... Humanized B-3 Antibody Fragments,fusion Proteins, And Uses Thereof. Uses...
	2/28/1995	United States Of America	Assignee	Application Patent	08331397 5981726	Himeric And Mutationally Stabilized Tumor-specific B1, B3 And B5 Antibod... Himeric And Mutationally Stabilized Tumor-specific B1, B3 And B5 Antibo...
	2/21/1995	Health And Human Services, United States...	Assignee	Application Patent	08331398 5608039	Single Chain B3 Antibody Fusinon Proteins And Their Uses Single Chain B3 Antibody Fusinon Proteins And Their Uses
	3/4/1991	United States Of America	Assignee	Application Patent	07663455 5328984	Recombinant Chimeric Proteins Deliverable Across Cellular Membranes Into... Recombinant Chimeric Proteins Deliverable Across Cellular Membranes Into...
	2/4/1991	United States Of America	Assignee	Application Patent	07620939 6099842	Recombinant Immunotoxin Composed Of A Single Chain Antibody Reacting Wit... Recombinant Immunotoxin Composed Of A Single Chain Antibody Reacting Wit...
	12/10/1990	United States Of America	Assignee	Application Patent	07596289 5242813	Mouse Monoclonal Antibodies Specific For Normal Primate Tissue, Malignan... Mouse Monoclonal Antibodies Specific For Normal Primate Tissue, Malignan...
	5/14/1990	United States Of America	Assignee	Application Patent	07522563 5458878	P. Exotoxin Fusio Proteins Have Cooh Terminal Alterations Which Increase... P. Exotoxin Fusio Proteins Have Cooh Terminal Alterations Which Increase...
	5/12/1989	United States Of America	Assignee	Application Patent	07351448 5082927	Selectively Cytotoxic Il-4-pe40 Fusion Protein Selectively Cytotoxic Il-4-pe40 Fusion Protein
	7/22/1988	United States Of America	Assignee	Application Patent	07223270 5206353	Cd-4/cytotoxic Gene Fusions Cd-4/cytotoxic Gene Fusions
	7/24/1986	United States Of America	Assignee	Application Patent	06888960 4806494	Monoclonal Antibody Against Ovarian Cancer Cells (ovb-3) Monoclonal Antibody Against Ovarian Cancer Cells (ovb-3)
	4/2/1984	United States Of America As Represented ...	Assignee	Application Patent	06574173 4545985	Pseudomonas Exotoxin Conjugate Immunotoxins Pseudomonas Exotoxin Conjugate Immunotoxins

38 Rows Total

Pastan, Ira has not been involved in any trademark assignment transactions in the PlainSite database.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.